kidney cancer

NEW YORK (GenomeWeb) — Rosetta Genomics said today that it has received final approval from the New York State Department of Health for use of its Rosetta Kidney Cancer Test on patient samples from the state.

NEW YORK (GenomeWeb) – Fluxion Biosciences said today that it will collaborate with the Stanford University School of Medicine on developing molecular diagnostic tests to identify circulating tumor cells.

NEW YORK (GenomeWeb News) – 20/20 GeneSystems said on Monday it was awarded a $750,000 contract by the National Cancer Institute to develop a test for predicting which patients with advanced stage kidney cancer may benefit from anti-angiogenic therapy.

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that the New York State Department of Health has given conditional approval for the company's Rosetta Kidney Cancer Test for patient samples originating from New York.

NEW YORK (GenomeWeb News) – A pair of studies appearing online today in Science Translational Medicine suggest that kidney tumors stemming from exposure to a plant compound once used in Chinese medicine are characterized by both rampant somatic mutation rates and a distinct mutational si

NEW YORK (GenomeWeb News) – A Japanese team has published an integrated genomic and transcriptomic analysis focused on a form of kidney cancer called clear-cell renal cell carcinoma.

NEW YORK (GenomeWeb News) – A Medicare contractor has issued a final coverage determination confirming coverage for one of Rosetta Genomics' microRNA-based cancer diagnostics, but denying Medicare coverage for two of the firm's other tests, Rosetta announced today.

NEW YORK (GenomeWeb News) – Cancer Genetics said today it has received CLIA and New York approval to offer its microarray-based kidney cancer test.